News And Announcements
Faron sees some encouraging data in ongoing INTEREST analysis
Clinical stage biopharmaceutical company Faron Pharmaceuticals announced preliminary biomarker data from its Phase III INTEREST trial of ‘Traumakine’ for the treatment of acute respiratory distress syndrome (ARDS) on Thursday, reporting that the data confirmed that Traumakine treatment did not produce consistent interferon-beta bioactivity across the treatment group.
Revolution Bars warns on earnings as weather, absence of CEO weigh
Revolution Bars was under the cosh on Thursday as it warned that adjusted earnings for the year would be in line with last year's results and below analysts' expectations amid challenging trading conditions, with the blamed laid on weather and the absence of a CEO.
The Gym Group raises £24m to fund acquisition of easyGym sites
The Gym Group, which operates 133 low-cost gyms, said on Thursday that it has raised gross proceeds of around £24m in a placing, which will be used to fund the acquisition of 13 easyGym sites.
Majestic Wine swings to profit but warns market to remain tough
Majestic Wine said on Thursday that it swung to a profit in the year to 2 April 2018 but warned that it expects the market to remain tough.
Safestore reports strong occupancy as profits rise
Safestore said occupancy performance at its storage facilities was the strongest for five years as the company posted a 12% rise in first-half earnings.
Solid leasing momentum continues at Intu
Intu Properties added Hotel Chocolat, Mitsubishi, The Florist and House to its list of new lessees on Thursday, as it told the market of ongoing momentum in its retail leasing following its April trading update.
GoCompare buys energy comparison site Energylinx for £10m
GoCompare. com has acquired energy comparison and switching specialist Energylinx for £10m in cash in a deal that will be financed through existing resources.
GSK buoyed as another generic Advair blocked, HIV treatment meets goals
GlaxoSmithKline shares were given a double boost on Thursday as the drugmaker said its two-drug treatment for HIV had met main targets in late-stage studies, while news also emerged that one potential rival to its blockbuster Advair had been blocked by US regulators.
UK and Nigeria remain tough markets for PZ Cussons
Consumer products peddler PZ Cussons updated the market on Thursday, following the end of its trading year on 31 May, reporting that during the last few months of the year, performance in the UK has been in line with its revised expectations.
Aveva posts strong profit rise and targets £25m cost cuts
A strong performance by Aveva’s heritage business fuelled a 6. 8% rise in annual profit as the engineering and industrial software group targeted £25m of cost reductions from its merger with Schneider Electric.
Anglo American to develop Peru copper mine after $600m stake sale
Anglo American has agreed to sell a stake in its Quellaveco copper project in Peru to Mitsubishi Corporation for $500m that could rise to $600m in order to plough ahead with development.
Rolls-Royce to cut 4,600 jobs with axe falling mainly in UK
Rolls-Royce has announced 4,600 job cuts – mainly in the UK – to save £400m a year in the latest round of restructuring under chief executive Warren East.
Rathbones to buy Scottish wealth manager Speirs & Jeffrey
Rathbone Brothers has agreed to acquire Scotland's largest independent wealth manager, Speirs & Jeffrey, for an initial cash and shares consideration of £104m.
Comcast makes $65bn cash offer for Fox to trump Disney
Comcast made a $65bn bid to buy 21st Century Fox’s entertainment assets overnight, trumping an earlier takeover agreed with Disney for just over $52bn.